Holen Sie sich die Stockscreener-App
1.17
42.36%
-0.86
Schlusskurs vom Vortag:
$2.03
Offen:
$1.56
24-Stunden-Volumen:
1.33M
Relative Volume:
0.20
Marktkapitalisierung:
$3.25M
Einnahmen:
Nettoeinkommen (Verlust:
KGV:
-
EPS:
-
Netto-Cashflow:
1W Leistung:
+85.21%
1M Leistung:
+46.23%
6M Leistung:
-83.62%
1J Leistung:
-98.59%
1-Tages-Spanne:
$1.16
$1.61
1-Wochen-Bereich:
$0.433
$3.01
52-Wochen-Spanne:
$0.433
$115.74
Pomdoctor Ltd Adr Stock (POM) Company Profile
Firmenname
Pomdoctor Ltd Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare POM vs HITI, PETS, SCNX, RDGT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
POM
Pomdoctor Ltd Adr
|
1.17 | 3.25M | 0 | 0 | 0 | 0.00 |
HITI
High Tide Inc
|
2.59 | 230.88M | 486.49M | -33.29M | 10.86M | -0.3627 |
PETS
Petmed Express Inc
|
1.22 | 26.45M | 179.02M | -57.29M | -33.01M | -2.7487 |
SCNX
Scienture Holdings Inc
|
2.88 | 4.73M | 656.60K | -16.79M | -11.12M | -1.0743 |
RDGT
Ridgetech Inc
|
0.801 | 2.91M | 111.62M | 762.70K | 16.36M | -85.73 |
Pomdoctor Ltd Adr Aktie (POM) Neueste Nachrichten
POMDOCTOR LIMITED Announces the Termination of Its ADR Program and Trade Class A Ordinary Shares on Nasdaq - The Manila Times
POMDOCTOR LIMITED Announces the Termination of Its ADR Program and Trade Class A Ordinary Shares on Nasdaq - TradingView
POMDOCTOR LIMITED Announces the Termination of Its ADR Program and Trade Class A Ordinary Shares on Nasdaq - Yahoo Finance
POM Stock Price, Quote & News - Syfe
Convergence of AI, Wearable Technology, Remote Patient Monitoring and Real-World Healthcare: PomDoctor Ltd. (N A S D A Q: POM) - FinancialContent
POMDOCTOR LIMITED Announces Receipt of Nasdaq Staff Delisting Determination - The Manila Times
Pomdoctor Faces Nasdaq Delisting After Prolonged Bid-Price Noncompliance - TipRanks
PomDoctor Shareholders Back ADR Exit and 10-for-1 Share Consolidation - The Globe and Mail
PomDoctor Shareholders Back ADR Exit and 10-for-1 Share Consolidation - TipRanks
POMDOCTOR LIMITED American Depositary Shares (NASDAQ: POM) Stock Price, News & Analysis - Kalkine
POMDOCTOR LIMITED American Depositary Shares (NASDAQ: POM) Stock Price, News & Analysis - kalkine.ca
Pomdoctor to Showcase AI-Driven Healthcare Strategy at H.C. Wainwright Global Investment Conference - TipRanks
POMDOCTOR (POM) Stock: Slides -16.42%, Support at $0.67 2026-09-08WMA Signal - dars.gov.et
POMDOCTOR (POM) Stock: Slides -16.42%, Support at $0.67 2026-09-08Float Adjusted Cap - dars.gov.et
PomDoctor Sets September Vote on ADR Termination and 10-for-1 Share Consolidation - The Globe and Mail
PomDoctor Sets September Vote on ADR Termination and 10-for-1 Share Consolidation - TipRanks
Pomdoctor Launches U.S. Expansion Preparations With AI-Driven Healthcare Strategy - theglobeandmail.com
POMDOCTOR (POM): Moves 6.86% Lower to $0.95 in the Current Update; Price Setup: the $0.90 to $1.00 Range Remains in Focus in the Latest SessionDouble Bottom - siam.in
POMDOCTOR (POM): Moves 6.86% Lower to $0.95 in the Current Update; Price Setup: the $0.90 to $1.00 Range Remains in Focus in the Latest SessionProfitability Factor - dars.gov.et
POMDOCTOR (POM) Session: Finishes 6.86% Lower at $0.95; Price Levels: the Near-Term Reference Band Stretches From $0.90 to $1.00 in the Latest SessionInstitutional Sentiment - www.dars.gov.et
POMDOCTOR Limited (POM) Slips 5.2% to $0.97 as Stock Approaches Key SupportWMA Signal - dars.gov.et
POMDOCTOR Limited (POM) Slips 5.2% to $0.97 as Stock Approaches Key SupportVolatility Surface - dars.gov.et
(POM) stock price, news, quote and history - Yahoo Finance Singapore
Pomdoctor Unveils AI-Powered Healthcare Intelligence Flywheel to Drive Predictive Growth - The Globe and Mail
Pomdoctor Unveils AI-Powered Healthcare Intelligence Flywheel to Drive Predictive Growth - TipRanks
Pomdoctor Unveils Four-Tier Revenue Model to Drive AI-Enabled Healthcare Growth - TipRanks
These stocks are gapping in today's session - ChartMill
Pomdoctor Limited Restores Nasdaq Bid-Price Compliance, Avoids Delisting Risk - The Globe and Mail
Pomdoctor Limited Restores Nasdaq Bid-Price Compliance, Avoids Delisting Risk - TipRanks
PomDoctor regains Nasdaq compliance - TipRanks
Pomdoctor regains compliance with Nasdaq minimum bid price rule By Investing.com - Investing.com South Africa
Pomdoctor regains compliance with Nasdaq minimum bid price rule By Investing.com - Investing.com Canada
Pomdoctor regains compliance with Nasdaq minimum bid price rule By Investing.com - Investing.com UK
POMDOCTOR LIMITED Regains Compliance with Nasdaq Bid Price Requirement - Yahoo Finance
Pomdoctor regains compliance with Nasdaq minimum bid price rule - Investing.com
POMDOCTOR LIMITED Regains Compliance with Nasdaq Bid Price Requirement - The Manila Times
PomDoctor continues efforts to advance chronic disease management ecosystem - TipRanks
PomDoctor continues efforts to advance chronic disease management ecosystem - TipRanks
POMDOCTOR Deepens AI-Driven Chronic Disease Strategy as Predictive Healthcare Demand Surges - TipRanks
Pomdoctor shifts focus to AI-enabled healthcare infrastructure By Investing.com - Investing.com Australia
PomDoctor Shifts to Predictive Healthcare Infrastructure With Strategic Upgrade - TipRanks
Pomdoctor shifts focus to AI-enabled healthcare infrastructure By Investing.com - Investing.com South Africa
Pomdoctor to implement 1-for-18 reverse ADS split June 22 By Investing.com - Investing.com South Africa
PomDoctor Limited Sets June 22, 2026 Effective Date for One-for-Eighteen ADS Ratio Change - TipRanks
POMDOCTOR LIMITED Announces ADS Ratio Change to Be Effective on June 22, 2026 - Yahoo Finance
Pomdoctor to implement 1-for-18 reverse ADS split June 22 - Investing.com
POMDOCTOR to implement 1-for-18 reverse ADS spl... - Pluang
Pomdoctor to implement 1-for-18 reverse ADS split June 22 - Investing.com Nigeria
POM News | POMDOCTOR LTDADR (NASDAQ:POM) - ChartMill
POMDOCTOR Plans One-for-Eighteen Reverse ADS Split to Lift Nasdaq Trading Price - The Globe and Mail
Finanzdaten der Pomdoctor Ltd Adr-Aktie (POM)
Es liegen keine Finanzdaten für Pomdoctor Ltd Adr (POM) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
4.07%
3.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):